Senate NIH Caucus briefing to feature the Directors of the National Institute of Allergy and Infectious Diseases (NIAID) and the Vanderbilt Vaccine Center
November 11th, 2015
NIH FUNDING AND THE PROMISE OF BIOMEDICAL RESEARCH
November 17, 2015
Lunch Briefing: 12:15-1:30
Join the Senate NIH Caucus as we hear from:
Dr. Anthony S. Fauci is Director of the National Institute of Allergy and Infectious Diseases (NIAID), the lead institute of NIH for research on infectious and immunologic diseases. Dr. Fauci will discuss the latest scientific advances toward the development of a “universal” influenza vaccine that would protect against multiple seasonal and pandemic influenza viruses, as well as progress toward an HIV/AIDS vaccine. In addition, Dr. Fauci will provide an update on NIAID’s ongoing research response to the unprecedented Ebola outbreak in western Africa.
Dr. James E. Crowe, Jr. is Director of the Vanderbilt Vaccine Center, a research center of the Vanderbilt University Medical Center in Nashville, TN. Dr. Crowe will discuss recent advances in technology for rapid discovery and development of human antibody treatments against emerging infectious diseases, including Ebola and Marburg, chikungunya, dengue and avian influenza viruses. He will discuss current capabilities for expediting antibody therapy from discovery to clinical trials in a 1-2 year time frame and the critical role the NIH plays in supporting these efforts.
For more information, please feel free to contact Jessica Phillips (JP) Tyson in Senator Graham’s office (Jessica-Phillips_Tyson@lgraham.senate.gov) or Jasmine Hunt in Senator Durbin’s office (email@example.com).